2024 Musculoskeletal Oncology Symposium: A Clinical Approach
$50.00
Symposium · Orthopedics · 2024
MSKCC’s multidisciplinary symposium brings together 14 specialties for a clinical approach to bone and soft tissue tumors — Ewing sarcoma, chondrosarcoma, osteosarcoma, and metastatic lesions — through lectures and interactive case studies.
-
14specialties
-
2024year
- Primary bone and soft tissue tumor evaluation
- Limb-salvage and non-surgical treatment options
- Metastatic disease and oncological emergencies
Musculoskeletal oncology — evaluation, diagnosis, and management of bone and soft tissue tumors
MSKCC’s 2024 Musculoskeletal Oncology Symposium brings together 14 specialties for a clinical approach to bone and soft tissue tumors — Ewing sarcoma, chondrosarcoma, osteosarcoma, and metastatic musculoskeletal lesions. The program uses lectures and interactive case studies to address evaluation, diagnosis, management, and outcomes across the multidisciplinary oncology team.
-
14specialties
-
2024year
Inside this resource
Primary tumor evaluation and diagnostic workup
Faculty cover the evaluation pathway for suspected primary bone tumors, including imaging interpretation, biopsy principles, and staging systems specific to musculoskeletal oncology. Case-based sessions walk through diagnostic reasoning for chondrosarcoma, osteosarcoma, and Ewing sarcoma presentations encountered in clinical practice.
Surgical and non-surgical treatment approaches
Best practices in limb-salvage surgery, amputation decision-making, and non-surgical techniques including radiation and chemotherapy protocols are presented through interactive case discussions. Faculty address reconstruction options, functional outcomes, and the coordination required between surgical and medical oncology teams.
Metastatic disease and oncological emergencies
Additional sections cover metastatic musculoskeletal lesions, post-operative complication management, and oncological emergencies that require immediate clinical action. The case-based approach emphasizes real-world decision-making under time pressure across the multidisciplinary team.
Who this serves
- Orthopedic surgeons — managing primary and metastatic bone tumors in surgical practice
- Medical oncologists — coordinating systemic therapy with surgical management for MSK tumors
- Radiologists and pathologists — interpreting musculoskeletal imaging and biopsy specimens in oncologic context
Before you buy
Is this focused on a single specialty?
No — the symposium is designed for a multidisciplinary audience including orthopedic surgery, medical oncology, radiology, pathology, and surgical oncology.
Is this a nephrology course?
No — this is a cross-specialty product in the orthopedics and oncology categories addressing musculoskeletal tumors, not kidney disease.
The chart
| Format | Symposium (lectures + case studies) |
|---|---|
| Year | 2024 |
| Publisher | Memorial Sloan Kettering Cancer Center |
| Department | Nephrology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout
5 reviews for 2024 Musculoskeletal Oncology Symposium: A Clinical Approach
Add a review
Related products
Nephrology
Nephrology
Nephrology
Nephrology
Nephrology
Nephrology
Michael P. –
Well-organized symposium with clear clinical takeaways. The oncological emergencies section was a valuable addition to the program.
Karen L. –
Wished for more depth on pediatric bone tumors. The adult content was comprehensive but the pediatric section felt thin.
David M. –
MSKCC brings unmatched expertise in orthopedic oncology. The chondrosarcoma cases were particularly well-presented and thought-provoking.
Susan K. –
Good overview for non-surgical oncologists managing patients with bone metastases. The surgical sessions were informative even for me as a medical oncologist.
Richard H. –
The multidisciplinary approach is exactly what musculoskeletal oncology needs. Case discussions were clinically relevant and engaging.